Lupin and Mylan receive European Marketing Authorization for Nepexto, Biosimilar Etanercept EP News Bureau Jun 4, 2020 A a phase 3 clinical study in patients with moderate-to-severe active rheumatoid arthritis confirmed equivalence of Nepexto to…
Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia EP News Bureau Aug 1, 2019 Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…
